MedPath

Development of a *two hit* in vivo autologous transfusion model in healthy volunteers

Withdrawn
Conditions
transfusie gerelateerde longschade
acute hypoxia after blood transfusion
Registration Number
NL-OMON38238
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

1. Healthy male volunteer
2. Age * 18 years <35 years

Exclusion Criteria

1. No informed consent
2. Any abnormal test result during the screening prior to inclusion of the study (medical history, physical examination, ECG, blood and urine examination, spirometry, chest x-ray).
3. History of drugs abuse
4. Any present medication use on prescription
5. Smoking < 6 months
6. History of blood donation < 3 months
7. Previously transfused
8. Participation in any other medical study < 3 months
9. Participated in previous volunteer studies using LPS

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>A significant increase (p<0.05, ANOVA multiple comparison test) in either total<br /><br>protein leakage, neutrophil activation or coagulation activation in the<br /><br>BAL-fluid of the subjects receiving a *first hit* of LPS and one unit of RBCs<br /><br>stored for 35 days compared to controls. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>N/A</p><br>
© Copyright 2025. All Rights Reserved by MedPath